525 related articles for article (PubMed ID: 9918831)
21. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells.
Goppelt-Struebe M; Schaefer D; Habenicht AJ
Br J Pharmacol; 1997 Oct; 122(4):619-24. PubMed ID: 9375956
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
[TBL] [Abstract][Full Text] [Related]
23. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
24. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes.
DeWitt DL; Meade EA
Arch Biochem Biophys; 1993 Oct; 306(1):94-102. PubMed ID: 8215426
[TBL] [Abstract][Full Text] [Related]
25. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism.
Nunokawa Y; Oikawa S; Tanaka S
Biochem Biophys Res Commun; 1996 Jun; 223(2):347-52. PubMed ID: 8670285
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium.
Jun SS; Chen Z; Pace MC; Shaul PW
Circ Res; 1999 Feb; 84(2):193-200. PubMed ID: 9933251
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun.
Brostjan C; Anrather J; Csizmadia V; Natarajan G; Winkler H
J Immunol; 1997 Apr; 158(8):3836-44. PubMed ID: 9103451
[TBL] [Abstract][Full Text] [Related]
28. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages.
Masferrer JL; Reddy ST; Zweifel BS; Seibert K; Needleman P; Gilbert RS; Herschman HR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1340-4. PubMed ID: 7932188
[TBL] [Abstract][Full Text] [Related]
29. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids.
Schuetz JD; Silverman JA; Thottassery JV; Furuya KN; Schuetz EG
Cell Growth Differ; 1995 Oct; 6(10):1321-32. PubMed ID: 8845310
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene in vascular endothelial cells.
Inoue H; Tanabe T
Adv Exp Med Biol; 1997; 407():139-44. PubMed ID: 9321944
[No Abstract] [Full Text] [Related]
31. Identification of a novel glucocorticoid response unit (GRU) in the 5'-flanking region of the mouse IL-2 receptor alpha gene.
Lamas M; Campos JR; Silva AG
Cytokine; 1997 Dec; 9(12):973-81. PubMed ID: 9417808
[TBL] [Abstract][Full Text] [Related]
32. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah K; Telang N; Ramonetti JT; Araki R; DeVito B; Weksler BB; Dannenberg AJ
Cancer Res; 1996 Oct; 56(19):4424-9. PubMed ID: 8813136
[TBL] [Abstract][Full Text] [Related]
33. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
Li J; Johnson TA; Hanson LA; Beer DG
Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
[TBL] [Abstract][Full Text] [Related]
34. Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes.
Yamaoka K; Otsuka T; Niiro H; Arinobu Y; Niho Y; Hamasaki N; Izuhara K
J Immunol; 1998 Jan; 160(2):838-45. PubMed ID: 9551919
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium.
Ji YS; Xu Q; Schmedtje JF
Circ Res; 1998 Aug; 83(3):295-304. PubMed ID: 9710122
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA.
Gomi M; Moriwaki K; Katagiri S; Kurata Y; Thompson EB
Cancer Res; 1990 Mar; 50(6):1873-8. PubMed ID: 2106390
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2.
Imaizumi T; Aratani S; Nakajima T; Carlson M; Matsumiya T; Tanji K; Ookawa K; Yoshida H; Tsuchida S; McIntyre TM; Prescott SM; Zimmerman GA; Satoh K
Biochem Biophys Res Commun; 2002 Mar; 292(1):274-9. PubMed ID: 11890704
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 Nov; 278(3):790-6. PubMed ID: 11095985
[TBL] [Abstract][Full Text] [Related]
39. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms.
Simoncini T; Maffei S; Basta G; Barsacchi G; Genazzani AR; Liao JK; De Caterina R
Circ Res; 2000 Jul; 87(1):19-25. PubMed ID: 10884367
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region.
Gou Q; Liu CH; Ben-Av P; Hla T
Biochem Biophys Res Commun; 1998 Jan; 242(3):508-12. PubMed ID: 9464246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
